Related Experiment Video
Updated: Jan 13, 2026
06:08
Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump
Published on: March 11, 2017
11.1K
Admixture Compatibility Studies in Parenteral Formulations: Packaging, Device, and Regulatory Perspectives
Chetana Eknure1, Vishvesh Joshi2, Yogeshwar Bachhav3
1Adex Pharma, Tilak Nagar, Mumbai, Maharashtra, 400089, India.
AAPS Pharmscitech
|January 9, 2026
Summary
Parenteral therapies face risks from drug incompatibilities and device interactions. Admixture compatibility studies are crucial for ensuring the safety and efficacy of these vital treatments.
Area of Science:
- Pharmacology
- Materials Science
- Clinical Pharmacy
Background:
- Parenteral therapies are essential in critical care, oncology, and nutrition.
- Safety concerns arise from admixture incompatibilities and drug-device interactions.
- These issues impact drug stability, efficacy, and patient outcomes.
Purpose of the Study:
- To review physicochemical and material-based incompatibilities in parenteral formulations.
- To highlight risks like precipitation, pH shifts, and leachables.
- To examine interactions with packaging systems and regulatory requirements.
Main Methods:
- Literature synthesis of current scientific understanding.
- Critical examination of interactions with glass, plastics, elastomers, and siliconized components.
- Review of regulatory standards for extractables, leachables, and container-closure integrity.
Main Results:
- Incompatibilities can lead to precipitation, pH shifts, phase separation, and adsorption.
- Documented risks include treatment failure, infusion reactions, and product recalls.
- Interactions with packaging materials pose significant safety challenges.
Conclusions:
- Admixture compatibility studies are essential for safe parenteral drug delivery.
- Emerging strategies like advanced packaging and monitoring can enhance safety.
- Ensuring compatibility is key to the reliability of parenteral therapies.
Related Concept Videos
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
193
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
193
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
146
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
146
01:27Bioavailability Enhancement: Drug Permeability Enhancement
183
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
183
01:25Routes of Drug Administration: Parenteral
2.8K
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
2.8K
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
232
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
232
01:28Factors Influencing Drug Absorption: Pharmaceutical Parameters
392
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
392